Organ on chip models for the evaluation of microbubble based therapeutic delivery

Matthew Bourn; Damien V. B. Batchelor; Nicola Ingram; James R. McLaughlan; P. Louise Coletta; Stephen D. Evans; Sally A. Peyman

doi:10.1117/12.2551605

21 February 2020 Organ on chip models for the evaluation of microbubble based therapeutic delivery

Matthew Bourn, Damien V. B. Batchelor, Nicola Ingram, James R. McLaughlan, P. Louise Coletta, Stephen D. Evans, Sally A. Peyman

Author Affiliations +

Proceedings Volume 11235, Microfluidics, BioMEMS, and Medical Microsystems XVIII; 112350K (2020) https://doi.org/10.1117/12.2551605
Event: SPIE BiOS, 2020, San Francisco, California, United States

Abstract

Current in vitro cancer models used for screening potential new therapeutic agents are often 2D monolayers of cells grown on the bottom of a petri dish or culture flask. These simplistic models lack many of the important biological features of in vivo tissue growth, such as the presence of an extracellular matrix (ECM) and cell interactions associated with this in a 3D structure. The use of spheroids for drug testing has gone some way to address the limitations of 2D cultures, however spheroids are still typically handled in static environments that neglect important physical aspects of the microenvironment present in vivo, such as fluid flow and associated shear stresses. In addition, assays involving spheroids still require many manual pipetting steps in which fluid is replaced in a single fluidic operation which is labor intensive, can be damaging to spheroid structural integrity and is an action that is physiologically incorrect. Here we present a microfluidic platform for the high-throughput trapping, culture and exposure of 3D co-culture spheroids to drugs under physiologically relevant fluid flow. The device is self-supportive, allowing multiple devices to be in an incubator at once without peripheral pumps. Spheroids can be monitored in situ with microscopy and the device is designed such that spheroids can be recovered for quantitative off-chip analysis. As a first demonstration, the effectiveness of co-delivering ultrasound (US) triggered microbubbles (MBs) with doxorubicin (DOX) was evaluated. Spheroids exposed to 3 μM DOX co-delivered with MBs showed a 51% reduction is spheroid viability compared to a 25% reduction in viability of free DOX alone.

Conference Presentation

Citation Download Citation

Matthew Bourn, Damien V. B. Batchelor, Nicola Ingram, James R. McLaughlan, P. Louise Coletta, Stephen D. Evans, and Sally A. Peyman "Organ on chip models for the evaluation of microbubble based therapeutic delivery", Proc. SPIE 11235, Microfluidics, BioMEMS, and Medical Microsystems XVIII, 112350K (21 February 2020); https://doi.org/10.1117/12.2551605

ACCESS THE FULL ARTICLE

INSTITUTIONAL
Select your institution to access the SPIE Digital Library.

SELECT YOUR INSTITUTION

PERSONAL
Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.

PERSONAL SIGN IN

No SPIE Account? Create one

PURCHASE THIS CONTENT

SUBSCRIBE TO DIGITAL LIBRARY

50 downloads per 1-year subscription

Members: $195

Non-members: $335 ADD TO CART

25 downloads per 1 - year subscription

Members: $145

Non-members: $250 ADD TO CART

PURCHASE SINGLE ARTICLE

Includes PDF, HTML & Video, when available